177 related articles for article (PubMed ID: 8408149)
21. Role of whole body positron emission tomography/computed tomography scan with 18F-fluorodeoxyglucose in patients with biopsy proven tumor metastases from unknown primary site.
Pelosi E; Pennone M; Deandreis D; Douroukas A; Mancini M; Bisi G
Q J Nucl Med Mol Imaging; 2006 Mar; 50(1):15-22. PubMed ID: 16557200
[TBL] [Abstract][Full Text] [Related]
22. Effective examination methods for identifying the primary origins of metastatic bone tumors of unknown primary origin during the initial visit: A retrospective chart review study.
Fujibuchi T; Imai H; Kidani T; Miura H
SAGE Open Med; 2022; 10():20503121221097582. PubMed ID: 35646367
[TBL] [Abstract][Full Text] [Related]
23. Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors.
Brage ME; Simon MA
Orthopedics; 1992 May; 15(5):589-96. PubMed ID: 1589351
[TBL] [Abstract][Full Text] [Related]
24. Whole-body MR imaging: evaluation of patients for metastases.
Lauenstein TC; Goehde SC; Herborn CU; Goyen M; Oberhoff C; Debatin JF; Ruehm SG; Barkhausen J
Radiology; 2004 Oct; 233(1):139-48. PubMed ID: 15317952
[TBL] [Abstract][Full Text] [Related]
25. Primary bone metastasis as first manifestation of an unknown primary tumour.
García Carretero R; Romero Brugera M; Rebollo-Aparicio N; El Bouayadi Mohamed L
BMJ Case Rep; 2015 Sep; 2015():. PubMed ID: 26338244
[TBL] [Abstract][Full Text] [Related]
26. Clinical value of 18F-FDG PET-CT in detecting primary tumor for patients with carcinoma of unknown primary.
Han A; Xue J; Hu M; Zheng J; Wang X
Cancer Epidemiol; 2012 Oct; 36(5):470-5. PubMed ID: 22504050
[TBL] [Abstract][Full Text] [Related]
27. Spinal epidural metastasis as the initial manifestation of malignancy: clinical features and diagnostic approach.
Schiff D; O'Neill BP; Suman VJ
Neurology; 1997 Aug; 49(2):452-6. PubMed ID: 9270576
[TBL] [Abstract][Full Text] [Related]
28. Effectiveness of X-ray and computed tomography screening for assessing pulmonary involvement in patients with head and neck squamous cell carcinoma.
Leong SC; Javed F; Elliot S; Mortimore S
J Laryngol Otol; 2008 Sep; 122(9):961-6. PubMed ID: 18177532
[TBL] [Abstract][Full Text] [Related]
29. Bone metastases as the first manifestation of a tumour.
Barón MG; de la Gándara I; Espinosa E; de Paredes ML; Zamora P; Mondéjar JL
Int Orthop; 1991; 15(4):373-6. PubMed ID: 1725677
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic strategy for bone and soft-tissue tumors.
Simon MA; Finn HA
Instr Course Lect; 1994; 43():527-36. PubMed ID: 9097183
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic strategy for bone and soft-tissue tumors.
Simon MA; Finn HA
J Bone Joint Surg Am; 1993 Apr; 75(4):622-31. PubMed ID: 8478392
[TBL] [Abstract][Full Text] [Related]
32. The usefulness of 99mTc-tetrofosmin SPECT in the detection of lung metastases from extrapulmonary primary tumors.
Spanu A; Solinas ME; Farris A; Arru A; Chessa F; Madeddu G; Falchi A; Madeddu G
Radiol Med; 2004; 107(1-2):113-27. PubMed ID: 15031703
[TBL] [Abstract][Full Text] [Related]
33. Strategy for identifying primary malignancies with inaugural bone metastases.
Alcalay M; Azais I; Brigeon B; Babin P; Vandermarcq P; Debiais F; Bontoux D
Rev Rhum Engl Ed; 1995 Nov; 62(10):632-42. PubMed ID: 8624672
[TBL] [Abstract][Full Text] [Related]
34. [Bone metastasis revealing a primary prostate cancer].
El Otmany A; Bouklata S; Hafid H; Chami I; Jalil A; Benjelloun S; Souadka A; Belabbas M
J Radiol; 2000 Sep; 81(9):990-1. PubMed ID: 10992100
[TBL] [Abstract][Full Text] [Related]
35. The need to consider survival, outcome, and expense when evaluating and treating patients with unknown primary carcinoma.
Schapira DV; Jarrett AR
Arch Intern Med; 1995 Oct; 155(19):2050-4. PubMed ID: 7575063
[TBL] [Abstract][Full Text] [Related]
36. Sensitivity in detecting osseous lesions depends on anatomic localization: planar bone scintigraphy versus 18F PET.
Schirrmeister H; Guhlmann A; Elsner K; Kotzerke J; Glatting G; Rentschler M; Neumaier B; Träger H; Nüssle K; Reske SN
J Nucl Med; 1999 Oct; 40(10):1623-9. PubMed ID: 10520701
[TBL] [Abstract][Full Text] [Related]
37. The added value of 18F-fluorodeoxyglucose positron emission tomography computed tomography in patients with neck lymph node metastases from an unknown primary malignancy.
Prowse SJ; Shaw R; Ganeshan D; Prowse PM; Hanlon R; Lewis-Jones H; Wieshmann H
J Laryngol Otol; 2013 Aug; 127(8):780-7. PubMed ID: 23919968
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic value of 99mTc-MDP SPECT/spiral CT combined with three-phase bone scintigraphy in assessing suspected bone tumors in patients with no malignant history.
Zhang Y; Shi H; Li B; Xiu Y; Cai L; Gu Y; Chen S
Nucl Med Commun; 2015 Jul; 36(7):686-94. PubMed ID: 25757199
[TBL] [Abstract][Full Text] [Related]
39. Challenges of utilizing immunostains to facilitate the diagnosis and management of metastatic adenocarcinoma.
Hill HC
J Natl Med Assoc; 2008 Dec; 100(12):1469-73. PubMed ID: 19110917
[TBL] [Abstract][Full Text] [Related]
40. Diagnostic evaluation of squamous cell carcinoma metastatic to cervical lymph nodes from an unknown head and neck primary site.
Cianchetti M; Mancuso AA; Amdur RJ; Werning JW; Kirwan J; Morris CG; Mendenhall WM
Laryngoscope; 2009 Dec; 119(12):2348-54. PubMed ID: 19718744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
